$22.79
-0.37-1.60%
In chiusura: Nov 20, 4:00 PM EST
$22.33
-0.46-2.02%
After hour: 6:46 PM EST
Immunovant segnala gli utili su base trimestrale. Questi report sugli utili trimestrali offrono agli investitori uno sguardo ai risultati finanziari di un'azienda per un periodo di 3 mesi. I report sugli utili includono quasi sempre i risultati EPS e i ricavi.
Analizza lo storico degli utili di Immunovant utilizzando ordinamenti e filtri avanzati.
Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
IMVT | Immunovant | -$0.76 | -$0.71 | — | — | $0.00 | $2.40M | — | — | 02/05/2026 | |
IMVT | Immunovant | -$0.74 | -$0.72 | -$0.73 | -1.39% | $0.00 | — | $0.00 | — | 11/10/2025 | |
IMVT | Immunovant | -$0.60 | -$0.68 | -$0.71 | -4.41% | $0.00 | — | $0.00 | — | 08/11/2025 | |
IMVT | Immunovant | -$0.52 | -$0.72 | -$0.64 | 11.11% | $0.00 | — | $0.00 | — | 05/29/2025 | |
IMVT | Immunovant | -$0.36 | -$0.76 | -$0.76 | 0.00% | $0.00 | — | $0.00 | — | 02/06/2025 | |
IMVT | Immunovant | -$0.45 | -$0.60 | -$0.74 | -23.33% | $0.00 | — | $0.00 | — | 11/07/2024 | |
IMVT | Immunovant | -$0.57 | -$0.53 | -$0.60 | -13.21% | $0.00 | — | $0.00 | — | 08/06/2024 | |
IMVT | Immunovant | -$0.46 | -$0.43 | -$0.52 | -20.93% | $0.00 | — | $0.00 | — | 05/29/2024 | |
IMVT | Immunovant | -$0.49 | -$0.43 | -$0.36 | 16.28% | $0.00 | — | $0.00 | — | 02/12/2024 | |
IMVT | Immunovant | -$0.41 | -$0.48 | -$0.45 | 6.25% | $0.00 | — | $0.00 | — | 11/09/2023 | |
IMVT | Immunovant | -$0.35 | -$0.45 | -$0.57 | -26.67% | $0.00 | — | $0.00 | — | 08/10/2023 | |
IMVT | Immunovant | -$0.41 | -$0.43 | -$0.46 | -6.98% | $0.00 | — | $0.00 | — | 05/22/2023 | |
IMVT | Immunovant | -$0.36 | -$0.39 | -$0.49 | -25.64% | $0.00 | — | $0.00 | — | 02/03/2023 | |
IMVT | Immunovant | -$0.35 | -$0.39 | -$0.41 | -5.13% | $0.00 | — | $0.00 | — | 11/04/2022 | |
IMVT | Immunovant | -$0.31 | -$0.40 | -$0.35 | 12.50% | $0.00 | — | $0.00 | — | 08/05/2022 | |
IMVT | Immunovant | -$0.29 | -$0.38 | -$0.41 | -7.89% | $0.00 | — | $0.00 | — | 06/08/2022 | |
IMVT | Immunovant | -$0.32 | -$0.33 | -$0.36 | -9.09% | $0.00 | — | $0.00 | — | 02/04/2022 | |
IMVT | Immunovant | -$0.25 | -$0.30 | -$0.35 | -16.67% | $0.00 | — | $0.00 | — | 11/05/2021 | |
IMVT | Immunovant | -$0.38 | -$0.30 | -$0.31 | -3.33% | $0.00 | — | $0.00 | — | 08/09/2021 | |
IMVT | Immunovant | -$0.38 | -$0.32 | -$0.29 | 9.38% | $0.00 | — | $0.00 | — | 06/01/2021 | |
IMVT | Immunovant | -$0.28 | — | -$0.32 | — | — | — | $0.00 | — | 02/16/2021 |
| Trimestre fiscale | Data segnalata | EPS effettivo | EPS stimato | Sorpresa% |
|---|---|---|---|---|
| Q2 | 2025-11-10 | $-0.73 | $-0.72 | -1.39 % |
| Q1 | 2025-08-11 | $-0.71 | $-0.68 | -4.41 % |
| Q4 | 2025-05-29 | $-0.64 | $-0.72 | 11.1 % |
| Q3 | 2025-02-06 | $-0.76 | $-0.76 | 0.00 % |
| Trimestre fiscale | Data segnalata | Entrate effettive | Entrate stimate | Sorpresa% |
|---|---|---|---|---|
Si prevede che Immunovant (IMVT) fornisca risultati il febbraio 5, 2026. Gli ultimi risultati sono stati pubblicati il novembre 10, 2025 per il Q2.
L'EPS effettivo era $-0.73, che mancato la stima di $-0.72.
Le entrate effettive sono state $0K, che centrato la stima di $0K.
Sfoglia stime sugli utili, EPS e ricavi su tutte le azioni.